Conatus Pharmaceuticals Inc. 4
4 · Conatus Pharmaceuticals Inc. · Filed Jan 11, 2017
Insider Transaction Report
Form 4
Cashion Charles
SVP, Finance, CFO and Sec.
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2017-01-09−42,424→ 0 totalExercise: $0.99From: 2011-02-17Exp: 2021-02-16→ Common Stock (42,424 underlying) - Exercise/Conversion
Common Stock
2017-01-09$0.99/sh+42,424$42,000→ 42,424 total
Holdings
- 144,738(indirect: See footnote.)
Common Stock
Footnotes (1)
- [F1]Held in a trust of which Mr. Cashion is a trustee.